Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CODX stock hub

Co-Diagnostics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CODXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CODX

In the news

Latest news · CODX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-125.9

P25 -106.6P50 -46.9P75 -3.1

ROIC-157.1

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CODX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001692415
Company name	Co-Diagnostics, Inc.
Country	United States
Country code	US
Cusip	189763105
Employees	115
Employees Change	-17%
Employees Change Percent	-12.88
Enterprise value	$-1.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US1897632048
Last refreshed	2026-05-10
Market cap	$9.1M
Market cap category	Nano-Cap
Price	$2.53
Price currency	USD
Rev Per Employee	5,412.95x
Sector	Healthcare
Sic	3841
Symbol	CODX
Website	https://co-dx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-514.54%
FCF yield	-327.37%
P/B ratio	0.26x
P/S ratio	14.64x
PS Forward	13.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	64.28%
Gross Profit	$400,112
Gross Profit Growth	-86.28%
Gross Profit Growth3 Y	-75.94%
Gross Profit Growth5 Y	-63.03%
Net Income	$-46.9M
Net Income Growth Years	0%
Pretax Margin	-7,793.22%
Profit Per Employee	$-407,791
ROA	-44.28
Roa5y	-16.1
ROCE	-147.5
ROE	-125.9
Roe5y	-37.99
ROIC	-157.1
Roic5y	-72.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.93%
Cagr3y	-60.6%
Cagr5y	-59.91%
EPS Growth Years	1
Revenue Growth	-84.1x
Revenue Growth Q	76.74x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-73.7x
Revenue Growth5 Y	-61.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$24.7M
Cash	$11.9M
Current Assets	$13.7M
Current Liabilities	$3.5M
Debt	$1.2M
Debt Equity	$0.06
Equity	$20.6M
Liabilities	$4.1M
Long Term Assets	$11M
Long Term Liabilities	$574,301
Net Cash	$10.6M
Net Cash By Market Cap	$117
Net Cash Growth	-61.41%
Net Debt Equity	$-0.52
Tangible Book Value	$13.4M
Tangible Book Value Per Share	$6.4
WACC	9.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.87
Inventory Turnover	0.22
Net Working Capital	$-1.1M
Quick ratio	3.42
Working Capital	$10.2M
Working Capital Turnover	$0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75.9%
200-day SMA	6.9
3Y total return	-93.89%
50-day SMA	1.96
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.96%
All Time High	929.7
All Time High Change	-99.73%
All Time High Date	2020-08-03
All Time Low	1.35
All Time Low Change	87.41%
All Time Low Date	2026-04-09
ATR	0.23
Beta	1.26
Beta1y	2.01
Beta2y	1.59
Ch YTD	-49.98
High	2.77
High52	46.5
High52 Date	2025-10-27
High52ch	-94.56%
Low	1.9
Low52	1.35
Low52 Date	2026-04-09
Low52ch	87.41%
Ma50ch	28.88%
Premarket Change Percent	12.95
Premarket Price	$2.18
Premarket Volume	3,836,413
Price vs 200-day SMA	-63.32%
RSI	72.77
RSI Monthly	33.22
RSI Weekly	38.19
Sharpe ratio	0.51x
Sortino ratio	1.42
Total Return	-31.55%
Tr YTD	-49.98
Tr1m	78.17%
Tr1w	63.23%
Tr3m	8.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Buy
Earnings EPS Estimate	$-3.6
Earnings Revenue Estimate	200,000x
Earnings Revenue Estimate Growth	297.8x
Operating Income	$-31.3M
Operating margin	-5,025.5
Price target	$90
Price Target Change	$3,457

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,499,256%
Float Percent	97.14%
Shares Insiders	2.86%
Shares Institutions	10.55%
Shares Out	3,602,465
Shares Qo Q	49.14%
Shares Yo Y	31.55%
Short Float	1.31%
Short Ratio	0.02
Short Shares	1.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-32.1M
Average Volume	621,834.05x
Bv Per Share	9.85
CAPEX	$-700,047
Ch1m	78.17
Ch1w	63.23
Ch1y	-75.9
Ch3m	8.58
Ch3y	-93.89
Ch5y	-98.96
Ch6m	-79.23
Change	31.09%
Change From Open	17.13
Close	1.93
Days Gap	11.92
Depreciation Amortization	1,106,808
Dollar Volume	26,146,171.2
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-31.3M
EBITDA	$-30.2M
EPS	$-35.25
F Score	1
FCF	$-29.8M
FCF EV Yield	1,945.28x
FCF Per Share	$-8.28
Financing CF	11,811,583
Fiscal Year End	December
Founded	2,013
Income Tax	$-1.6M
Investing CF	26,273,407
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2026-01-02
Last Split Type	Reverse
Ma150	5.96
Ma150ch	-57.57%
Ma20	1.64
Ma20ch	54.17%
Net CF	8,948,063
Next Earnings Date	2026-05-14
Open	2.16
Optionable	Yes
Position In Range	72.41
Post Close	2.53
Postmarket Change Percent	0.81
Postmarket Price	$2.55
Ppne	3,479,551
Pre Close	1.93
Price Date	2026-05-08
Ptbv Ratio	0.68
Relative Volume	16.62x
Revenue	622,489x
SBC By Revenue	361.14x
Share Based Comp	2,248,053
Tax By Revenue	-259.6x
Tr6m	-79.23%
Us State	Utah
Views	67
Volume	10,334,455
Z Score	-5.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CODX pay a dividend?

Capital-return profile for this ticker.

Performance

CODX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CODX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.5%

Float: +97.1% of shares outstanding

Insider ownership

+2.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CODX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.8

Above 70: short-term overbought

Price vs 200-day MA

-63.3%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CODX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CODX stock rating?

Co-Diagnostics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CODX analysis?

The full report lives at /stocks/CODX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CODX?

The latest report frames CODX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CODX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.